{"id":6765,"date":"2023-05-03T01:16:25","date_gmt":"2023-05-03T01:16:25","guid":{"rendered":"\/\/smallcapscn.x5view.co\/?p=6765"},"modified":"2023-08-29T17:57:48","modified_gmt":"2023-08-29T17:57:48","slug":"imugene-presents-abstract-pre-clinical-liver-cancer-treatment-response","status":"publish","type":"post","link":"https:\/\/smallcapscn.x5view.co\/?p=6765","title":{"rendered":"Imugene\u63d0\u4ea4\u4e86\u5173\u4e8e &#8220;\u4ee4\u4eba\u5370\u8c61\u6df1\u523b\u7684 &#8220;\u4e34\u5e8a\u524d\u809d\u764c\u6cbb\u7597\u53cd\u5e94\u7684\u8bba\u6587\u6458\u8981"},"content":{"rendered":"<p>Imugene (ASX: IMU)\u516c\u5e03\u4e86\u5176onCARlytics\u6280\u672f\u4e0eEureka Therapeutics\u7684Artemis T\u7ec6\u80de\u5e73\u53f0\u5728\u809d\u764c\u6a21\u578b\u4e0a\u7684\u201c\u4ee4\u4eba\u5370\u8c61\u6df1\u523b\u201d\u7684\u4e34\u5e8a\u524d\u4f53\u5185\u6297\u80bf\u7624\u53cd\u5e94\u3002<\/p>\n<p>\u8be5\u516c\u53f8\u5728\u7f8e\u56fd\u4e3e\u884c\u7684\u7f8e\u56fd\u57fa\u56e0\u4e0e\u7ec6\u80de\u7597\u6cd5\u534f\u4f1a\u5e74\u4f1a\u4e0a\u63d0\u4ea4\u4e86\u4e00\u4efd\u9898\u4e3a &#8220;\u4f7f\u7528onCARlytics\u548cArtemis CD19 T\u7ec6\u80de\u6709\u6548\u5730\u8054\u5408\u514d\u75ab\u7597\u6cd5\u5bf9\u6297\u809d\u7ec6\u80de\u764c &#8220;\uff08<em>Effective combination immunotherapy using onCARlytics and Artemis CD19 T cells against hepatocellular carcinoma\uff09<\/em>\u7684\u6458\u8981\u3002<\/p>\n<p>\u809d\u7ec6\u80de\u764c\uff08HCC\uff09\u662f\u6700\u5e38\u89c1\u7684\u809d\u764c\u7c7b\u578b\uff0c\u4e5f\u662f\u5168\u7403\u7b2c\u516d\u5927\u5e38\u89c1\u764c\u75c7\u3002<\/p>\n<p>\u8be5\u6458\u8981\u662f\u57fa\u4e8e\u5728\u4eba\u7c7b\u5f02\u79cd\u79fb\u690dHepG2\u6a21\u578b\u4e2d\u4f7f\u7528\u8be5\u7ec4\u5408\u7597\u6cd5\u7684\u4e34\u5e8a\u524d\u7814\u7a76\u3002<\/p>\n<p>\u8fd9\u79cd\u7ec4\u5408\u7597\u6cd5\u6d89\u53ca\u5229\u7528\u6eb6\u7624\u75c5\u6bd2\uff08OV\uff09\u7684\u80fd\u529b\uff0c\u5e76\u5f00\u53d1\u51fa\u4e00\u79cd\u540d\u4e3aCF330CD19t\uff08onCARlytics\uff09\u7684\u5d4c\u5408\u75ab\u82d7\u578bOV\uff0c\u5229\u7528CD19\u7279\u5f02\u6027T\u7ec6\u80de\u6765\u9776\u5411\u5b9e\u4f53\u7624\u3002<\/p>\n<p>&#8220;\u62a5\u544a\u8bf4\uff1a&#8221;\u4e3a\u4e86\u9776\u5411\u5b9e\u4f53\u80bf\u7624\u7ec6\u80de\u8868\u9762\u8868\u8fbe\u7684CD19t\uff0c\u6211\u4eec\u5c06onCARlytics\u4e0eCD19 Artemis T\u7ec6\u80de\u76f8\u7ed3\u5408\uff0c\u8fd9\u662f\u4e00\u79cd\u7531Artemis\u6297\u4f53-T\u7ec6\u80de\u53d7\u4f53\uff08AbTCR\uff09\u5e73\u53f0\u9a71\u52a8\u7684CD19\u9776\u5411\u6027\u91c7\u7528\u6027\u5de5\u7a0bT\u7ec6\u80de\uff0c\u3002<\/p>\n<p>\u62a5\u544a\u6307\u51fa\uff0c\u8fd9\u79cd\u7ec4\u5408\u7597\u6cd5\u5728HepG2\u6a21\u578b\u4e2d &#8220;\u8868\u73b0\u51fa\u4ee4\u4eba\u5370\u8c61\u6df1\u523b\u7684\u4f53\u5185\u6297\u80bf\u7624\u53cd\u5e94&#8221;\u3002<\/p>\n<p>\u901a\u8fc7\u4f7f\u7528\u8fd9\u79cd\u7b56\u7565\uff0cImugene\u516c\u53f8\u9884\u8ba1\u8fd9\u79cd\u7ec4\u5408\u7597\u6cd5\u53ef\u4ee5\u6269\u5927\u5230\u9488\u5bf9 &#8220;\u4e00\u7cfb\u5217\u5b9e\u4f53\u764c\u75c7&#8221;\u3002<\/p>\n<p>5\u6708\u4e0b\u65ec\uff0c\u5728\u7b2c26\u5c4a\u7f8e\u56fd\u57fa\u56e0\u548c\u7ec6\u80de\u6cbb\u7597\u534f\u4f1a\u5e74\u4f1a\uff08American Society of Gene and Cell Therapy\u2019s Annual Meeting\uff09\u4e0a\u5c06\u5bf9\u8be5\u7ed3\u679c\u8fdb\u884c\u5168\u9762\u4ecb\u7ecd\u3002<\/p>\n<h2>\u8d44\u91d1\u5145\u88d5\u7684\u514d\u75ab\u80bf\u7624\u7597\u6cd5\u7684\u8fdb\u5c55<\/h2>\n<p>\u4e0a\u4e2a\u6708\u672b\uff0c<a href=\"http:\/\/smallcaps-production.test\/imugene-lifts-bank-balance-rebate-progress-immune-oncology-therapies\/?lang=cn\">Imugene\u516c\u53f8\u900f\u9732\uff0c\u5b83\u5df2\u7ecf\u4ece\u6fb3\u5927\u5229\u4e9a\u653f\u5e9c\u83b7\u5f97\u4e861260\u4e07\u6fb3\u5143\u7684\u7814\u53d1\u9000\u7a0e<\/a>\uff0c\u8fd9\u5c06\u6709\u52a9\u4e8e\u8d44\u52a9\u5176\u514d\u75ab\u80bf\u7624\u7597\u6cd5\u7684\u8fdb\u5c55\u3002<\/p>\n<p>\u8be5\u516c\u53f8\u7684\u4ea7\u54c1\u7ec4\u5408\u5305\u62ec\u6eb6\u7624\u75c5\u6bd2\u7597\u6cd5\uff08VAXINIA\u6216CF33\uff09\u3001\u591a\u79cdB\u7ec6\u80de\u5019\u9009\u75ab\u82d7\u548c\u65b0\u5174\u6280\u672f\uff0c\u5305\u62econCARlytics\uff08CF33-CD19\uff09\u4e0eCAR-Ts\u7ec4\u5408\uff0c\u6216\u9488\u5bf9\u5b9e\u4f53\u7624\u7684CD19\u7684\u53cc\u89c4\u683c\u6297\u4f53\u3002<\/p>\n<p>\u8fd9\u4e9b\u514d\u75ab\u7597\u6cd5\u65e8\u5728\u5229\u7528\u60a3\u8005\u7684\u514d\u75ab\u7cfb\u7edf\u6765\u5e2e\u52a9\u5176\u6297\u51fb\u764c\u75c7\uff0c\u5e76\u53ef\u4f5c\u4e3a\u5355\u4e00\u7597\u6cd5\u6216\u4e0e\u5176\u4ed6\u7597\u6cd5\u7ed3\u5408\u4f7f\u7528\u3002<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Imugene (ASX: IMU)\u516c\u5e03\u4e86\u5176onCARlytics\u6280\u672f\u4e0eEureka Therapeutics\u7684Artemis T\u7ec6\u80de\u5e73\u53f0\u5728\u809d\u764c\u6a21\u578b\u4e0a\u7684\u201c\u4ee4\u4eba\u5370\u8c61\u6df1\u523b\u201d\u7684\u4e34\u5e8a\u524d\u4f53\u5185\u6297\u80bf\u7624\u53cd\u5e94\u3002 \u8be5\u516c\u53f8\u5728\u7f8e\u56fd\u4e3e\u884c\u7684\u7f8e\u56fd\u57fa\u56e0\u4e0e\u7ec6\u80de\u7597\u6cd5\u534f\u4f1a\u5e74\u4f1a\u4e0a\u63d0\u4ea4\u4e86\u4e00\u4efd\u9898\u4e3a &#8220;\u4f7f\u7528onCARlytics\u548cArtemis CD19 T\u7ec6\u80de\u6709\u6548\u5730\u8054\u5408\u514d\u75ab\u7597\u6cd5\u5bf9\u6297\u809d\u7ec6\u80de\u764c &#8220;\uff08Effective combination immunotherapy using onCARlytics and Artemis CD19 T cells against hepatocellular carcinoma\uff09\u7684\u6458\u8981\u3002 \u809d\u7ec6\u80de\u764c\uff08HCC\uff09\u662f\u6700\u5e38\u89c1\u7684\u809d\u764c\u7c7b\u578b\uff0c\u4e5f\u662f\u5168\u7403\u7b2c\u516d\u5927\u5e38\u89c1\u764c\u75c7\u3002 \u8be5\u6458\u8981\u662f\u57fa\u4e8e\u5728\u4eba\u7c7b\u5f02\u79cd\u79fb\u690dHepG2\u6a21\u578b\u4e2d\u4f7f\u7528\u8be5\u7ec4\u5408\u7597\u6cd5\u7684\u4e34\u5e8a\u524d\u7814\u7a76\u3002 \u8fd9\u79cd\u7ec4\u5408\u7597\u6cd5\u6d89\u53ca\u5229\u7528\u6eb6\u7624\u75c5\u6bd2\uff08OV\uff09\u7684\u80fd\u529b\uff0c\u5e76\u5f00\u53d1\u51fa\u4e00\u79cd\u540d\u4e3aCF330CD19t\uff08onCARlytics\uff09\u7684\u5d4c\u5408\u75ab\u82d7\u578bOV\uff0c\u5229\u7528CD19\u7279\u5f02\u6027T\u7ec6\u80de\u6765\u9776\u5411\u5b9e\u4f53\u7624\u3002 &#8220;\u62a5\u544a\u8bf4\uff1a&#8221;\u4e3a\u4e86\u9776\u5411\u5b9e\u4f53\u80bf\u7624\u7ec6\u80de\u8868\u9762\u8868\u8fbe\u7684CD19t\uff0c\u6211\u4eec\u5c06onCARlytics\u4e0eCD19 Artemis T\u7ec6\u80de\u76f8\u7ed3\u5408\uff0c\u8fd9\u662f\u4e00\u79cd\u7531Artemis\u6297\u4f53-T\u7ec6\u80de\u53d7\u4f53\uff08AbTCR\uff09\u5e73\u53f0\u9a71\u52a8\u7684CD19\u9776\u5411\u6027\u91c7\u7528\u6027\u5de5\u7a0bT\u7ec6\u80de\uff0c\u3002 \u62a5\u544a\u6307\u51fa\uff0c\u8fd9\u79cd\u7ec4\u5408\u7597\u6cd5\u5728HepG2\u6a21\u578b\u4e2d &#8220;\u8868\u73b0\u51fa\u4ee4\u4eba\u5370\u8c61\u6df1\u523b\u7684\u4f53\u5185\u6297\u80bf\u7624\u53cd\u5e94&#8221;\u3002 \u901a\u8fc7\u4f7f\u7528\u8fd9\u79cd\u7b56\u7565\uff0cImugene\u516c\u53f8\u9884\u8ba1\u8fd9\u79cd\u7ec4\u5408\u7597\u6cd5\u53ef\u4ee5\u6269\u5927\u5230\u9488\u5bf9 &#8220;\u4e00\u7cfb\u5217\u5b9e\u4f53\u764c\u75c7&#8221;\u3002 5\u6708\u4e0b\u65ec\uff0c\u5728\u7b2c26\u5c4a\u7f8e\u56fd\u57fa\u56e0\u548c\u7ec6\u80de\u6cbb\u7597\u534f\u4f1a\u5e74\u4f1a\uff08American Society of Gene and Cell Therapy\u2019s Annual Meeting\uff09\u4e0a\u5c06\u5bf9\u8be5\u7ed3\u679c\u8fdb\u884c\u5168\u9762\u4ecb\u7ecd\u3002 \u8d44\u91d1\u5145\u88d5\u7684\u514d\u75ab\u80bf\u7624\u7597\u6cd5\u7684\u8fdb\u5c55 \u4e0a\u4e2a\u6708\u672b\uff0cImugene\u516c\u53f8\u900f\u9732\uff0c\u5b83\u5df2\u7ecf\u4ece\u6fb3\u5927\u5229\u4e9a\u653f\u5e9c\u83b7\u5f97\u4e861260\u4e07\u6fb3\u5143\u7684\u7814\u53d1\u9000\u7a0e\uff0c\u8fd9\u5c06\u6709\u52a9\u4e8e\u8d44\u52a9\u5176\u514d\u75ab\u80bf\u7624\u7597\u6cd5\u7684\u8fdb\u5c55\u3002 \u8be5\u516c\u53f8\u7684\u4ea7\u54c1\u7ec4\u5408\u5305\u62ec\u6eb6\u7624\u75c5\u6bd2\u7597\u6cd5\uff08VAXINIA\u6216CF33\uff09\u3001\u591a\u79cdB\u7ec6\u80de\u5019\u9009\u75ab\u82d7\u548c\u65b0\u5174\u6280\u672f\uff0c\u5305\u62econCARlytics\uff08CF33-CD19\uff09\u4e0eCAR-Ts\u7ec4\u5408\uff0c\u6216\u9488\u5bf9\u5b9e\u4f53\u7624\u7684CD19\u7684\u53cc\u89c4\u683c\u6297\u4f53\u3002 \u8fd9\u4e9b\u514d\u75ab\u7597\u6cd5\u65e8\u5728\u5229\u7528\u60a3\u8005\u7684\u514d\u75ab\u7cfb\u7edf\u6765\u5e2e\u52a9\u5176\u6297\u51fb\u764c\u75c7\uff0c\u5e76\u53ef\u4f5c\u4e3a\u5355\u4e00\u7597\u6cd5\u6216\u4e0e\u5176\u4ed6\u7597\u6cd5\u7ed3\u5408\u4f7f\u7528\u3002<\/p>\n","protected":false},"author":3,"featured_media":19093,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[3],"tags":[458],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v17.3 (Yoast SEO v21.0) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Imugene\u63d0\u4ea4\u4e86\u5173\u4e8e &quot;\u4ee4\u4eba\u5370\u8c61\u6df1\u523b\u7684 &quot;\u4e34\u5e8a\u524d\u809d\u764c\u6cbb\u7597\u53cd\u5e94\u7684\u8bba\u6587\u6458\u8981<\/title>\n<meta name=\"description\" content=\"Imugene (ASX: IMU)\u516c\u5e03\u4e86\u5176onCARlytics\u6280\u672f\u4e0eEureka Therapeutics\u7684Artemis T\u7ec6\u80de\u5e73\u53f0\u5728\u809d\u764c\u6a21\u578b\u4e0a\u7684\u201c\u4ee4\u4eba\u5370\u8c61\u6df1\u523b\u201d\u7684\u4e34\u5e8a\u524d\u4f53\u5185\u6297\u80bf\u7624\u53cd\u5e94\u3002\" \/>\n<meta name=\"robots\" content=\"noindex, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Imugene\u63d0\u4ea4\u4e86\u5173\u4e8e &quot;\u4ee4\u4eba\u5370\u8c61\u6df1\u523b\u7684 &quot;\u4e34\u5e8a\u524d\u809d\u764c\u6cbb\u7597\u53cd\u5e94\u7684\u8bba\u6587\u6458\u8981\" \/>\n<meta property=\"og:description\" content=\"Imugene (ASX: IMU)\u516c\u5e03\u4e86\u5176onCARlytics\u6280\u672f\u4e0eEureka Therapeutics\u7684Artemis T\u7ec6\u80de\u5e73\u53f0\u5728\u809d\u764c\u6a21\u578b\u4e0a\u7684\u201c\u4ee4\u4eba\u5370\u8c61\u6df1\u523b\u201d\u7684\u4e34\u5e8a\u524d\u4f53\u5185\u6297\u80bf\u7624\u53cd\u5e94\u3002\" \/>\n<meta property=\"og:url\" content=\"https:\/\/smallcapscn.x5view.co\/imugene-presents-abstract-pre-clinical-liver-cancer-treatment-response\/\" \/>\n<meta property=\"og:site_name\" content=\"smallcapsCN\" \/>\n<meta property=\"article:published_time\" content=\"2023-05-03T01:16:25+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-08-29T17:57:48+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/smallcapscn.x5view.co\/wp-content\/uploads\/2023\/08\/Imugene-ASX-IMU-liver-cancer-treatment-immunotherapy-onCARlytics-Eureka-Therapeutics-Hepatocellular-carcinoma-CD19-targeting-T-cells.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"640\" \/>\n\t<meta property=\"og:image:height\" content=\"400\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Lorna Nicholas\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Lorna Nicholas\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/imugene-presents-abstract-pre-clinical-liver-cancer-treatment-response\/\",\"url\":\"https:\/\/smallcapscn.x5view.co\/imugene-presents-abstract-pre-clinical-liver-cancer-treatment-response\/\",\"name\":\"Imugene\u63d0\u4ea4\u4e86\u5173\u4e8e \\\"\u4ee4\u4eba\u5370\u8c61\u6df1\u523b\u7684 \\\"\u4e34\u5e8a\u524d\u809d\u764c\u6cbb\u7597\u53cd\u5e94\u7684\u8bba\u6587\u6458\u8981\",\"isPartOf\":{\"@id\":\"https:\/\/smallcapscn.x5view.co\/#website\"},\"datePublished\":\"2023-05-03T01:16:25+00:00\",\"dateModified\":\"2023-08-29T17:57:48+00:00\",\"author\":{\"@id\":\"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/3e816860d3443582b1918467347eeb60\"},\"description\":\"Imugene (ASX: IMU)\u516c\u5e03\u4e86\u5176onCARlytics\u6280\u672f\u4e0eEureka Therapeutics\u7684Artemis T\u7ec6\u80de\u5e73\u53f0\u5728\u809d\u764c\u6a21\u578b\u4e0a\u7684\u201c\u4ee4\u4eba\u5370\u8c61\u6df1\u523b\u201d\u7684\u4e34\u5e8a\u524d\u4f53\u5185\u6297\u80bf\u7624\u53cd\u5e94\u3002\",\"breadcrumb\":{\"@id\":\"https:\/\/smallcapscn.x5view.co\/imugene-presents-abstract-pre-clinical-liver-cancer-treatment-response\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/smallcapscn.x5view.co\/imugene-presents-abstract-pre-clinical-liver-cancer-treatment-response\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/imugene-presents-abstract-pre-clinical-liver-cancer-treatment-response\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/smallcapscn.x5view.co\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Imugene\u63d0\u4ea4\u4e86\u5173\u4e8e &#8220;\u4ee4\u4eba\u5370\u8c61\u6df1\u523b\u7684 &#8220;\u4e34\u5e8a\u524d\u809d\u764c\u6cbb\u7597\u53cd\u5e94\u7684\u8bba\u6587\u6458\u8981\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/#website\",\"url\":\"https:\/\/smallcapscn.x5view.co\/\",\"name\":\"smallcapsCN\",\"description\":\"Just another WordPress site\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/smallcapscn.x5view.co\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/3e816860d3443582b1918467347eeb60\",\"name\":\"Lorna Nicholas\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/431dd83ad861252293034fed39d5d7a5?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/431dd83ad861252293034fed39d5d7a5?s=96&d=mm&r=g\",\"caption\":\"Lorna Nicholas\"},\"description\":\"Lorna has more than 15 years' experience as a business\/finance journalist and editor. She has written for numerous industry publications reporting on various sectors, including: resources, energy, construction, biotech, pharma, science and technology, agriculture, and chemicals. Specialising in resources, Lorna has also covered a myriad of small and large cap ASX and dual-listed stocks.\",\"url\":\"https:\/\/smallcapscn.x5view.co\/?author=3\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Imugene\u63d0\u4ea4\u4e86\u5173\u4e8e \"\u4ee4\u4eba\u5370\u8c61\u6df1\u523b\u7684 \"\u4e34\u5e8a\u524d\u809d\u764c\u6cbb\u7597\u53cd\u5e94\u7684\u8bba\u6587\u6458\u8981","description":"Imugene (ASX: IMU)\u516c\u5e03\u4e86\u5176onCARlytics\u6280\u672f\u4e0eEureka Therapeutics\u7684Artemis T\u7ec6\u80de\u5e73\u53f0\u5728\u809d\u764c\u6a21\u578b\u4e0a\u7684\u201c\u4ee4\u4eba\u5370\u8c61\u6df1\u523b\u201d\u7684\u4e34\u5e8a\u524d\u4f53\u5185\u6297\u80bf\u7624\u53cd\u5e94\u3002","robots":{"index":"noindex","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"en_US","og_type":"article","og_title":"Imugene\u63d0\u4ea4\u4e86\u5173\u4e8e \"\u4ee4\u4eba\u5370\u8c61\u6df1\u523b\u7684 \"\u4e34\u5e8a\u524d\u809d\u764c\u6cbb\u7597\u53cd\u5e94\u7684\u8bba\u6587\u6458\u8981","og_description":"Imugene (ASX: IMU)\u516c\u5e03\u4e86\u5176onCARlytics\u6280\u672f\u4e0eEureka Therapeutics\u7684Artemis T\u7ec6\u80de\u5e73\u53f0\u5728\u809d\u764c\u6a21\u578b\u4e0a\u7684\u201c\u4ee4\u4eba\u5370\u8c61\u6df1\u523b\u201d\u7684\u4e34\u5e8a\u524d\u4f53\u5185\u6297\u80bf\u7624\u53cd\u5e94\u3002","og_url":"https:\/\/smallcapscn.x5view.co\/imugene-presents-abstract-pre-clinical-liver-cancer-treatment-response\/","og_site_name":"smallcapsCN","article_published_time":"2023-05-03T01:16:25+00:00","article_modified_time":"2023-08-29T17:57:48+00:00","og_image":[{"width":640,"height":400,"url":"https:\/\/smallcapscn.x5view.co\/wp-content\/uploads\/2023\/08\/Imugene-ASX-IMU-liver-cancer-treatment-immunotherapy-onCARlytics-Eureka-Therapeutics-Hepatocellular-carcinoma-CD19-targeting-T-cells.jpg","type":"image\/jpeg"}],"author":"Lorna Nicholas","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Lorna Nicholas"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/smallcapscn.x5view.co\/imugene-presents-abstract-pre-clinical-liver-cancer-treatment-response\/","url":"https:\/\/smallcapscn.x5view.co\/imugene-presents-abstract-pre-clinical-liver-cancer-treatment-response\/","name":"Imugene\u63d0\u4ea4\u4e86\u5173\u4e8e \"\u4ee4\u4eba\u5370\u8c61\u6df1\u523b\u7684 \"\u4e34\u5e8a\u524d\u809d\u764c\u6cbb\u7597\u53cd\u5e94\u7684\u8bba\u6587\u6458\u8981","isPartOf":{"@id":"https:\/\/smallcapscn.x5view.co\/#website"},"datePublished":"2023-05-03T01:16:25+00:00","dateModified":"2023-08-29T17:57:48+00:00","author":{"@id":"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/3e816860d3443582b1918467347eeb60"},"description":"Imugene (ASX: IMU)\u516c\u5e03\u4e86\u5176onCARlytics\u6280\u672f\u4e0eEureka Therapeutics\u7684Artemis T\u7ec6\u80de\u5e73\u53f0\u5728\u809d\u764c\u6a21\u578b\u4e0a\u7684\u201c\u4ee4\u4eba\u5370\u8c61\u6df1\u523b\u201d\u7684\u4e34\u5e8a\u524d\u4f53\u5185\u6297\u80bf\u7624\u53cd\u5e94\u3002","breadcrumb":{"@id":"https:\/\/smallcapscn.x5view.co\/imugene-presents-abstract-pre-clinical-liver-cancer-treatment-response\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/smallcapscn.x5view.co\/imugene-presents-abstract-pre-clinical-liver-cancer-treatment-response\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/smallcapscn.x5view.co\/imugene-presents-abstract-pre-clinical-liver-cancer-treatment-response\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/smallcapscn.x5view.co\/"},{"@type":"ListItem","position":2,"name":"Imugene\u63d0\u4ea4\u4e86\u5173\u4e8e &#8220;\u4ee4\u4eba\u5370\u8c61\u6df1\u523b\u7684 &#8220;\u4e34\u5e8a\u524d\u809d\u764c\u6cbb\u7597\u53cd\u5e94\u7684\u8bba\u6587\u6458\u8981"}]},{"@type":"WebSite","@id":"https:\/\/smallcapscn.x5view.co\/#website","url":"https:\/\/smallcapscn.x5view.co\/","name":"smallcapsCN","description":"Just another WordPress site","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/smallcapscn.x5view.co\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/3e816860d3443582b1918467347eeb60","name":"Lorna Nicholas","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/431dd83ad861252293034fed39d5d7a5?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/431dd83ad861252293034fed39d5d7a5?s=96&d=mm&r=g","caption":"Lorna Nicholas"},"description":"Lorna has more than 15 years' experience as a business\/finance journalist and editor. She has written for numerous industry publications reporting on various sectors, including: resources, energy, construction, biotech, pharma, science and technology, agriculture, and chemicals. Specialising in resources, Lorna has also covered a myriad of small and large cap ASX and dual-listed stocks.","url":"https:\/\/smallcapscn.x5view.co\/?author=3"}]}},"_links":{"self":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts\/6765"}],"collection":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=6765"}],"version-history":[{"count":1,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts\/6765\/revisions"}],"predecessor-version":[{"id":20563,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts\/6765\/revisions\/20563"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/media\/19093"}],"wp:attachment":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=6765"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=6765"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=6765"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}